Oncology: Focus on the Changing Therapeutic Landscape

CME Activities

• Higher-Risk Myelodysplastic Syndrome: A Team Approach to Optimizing Outcomes
  Medscape Education Oncology, February 2023
  Did you know there is a new way to categorize patients with myelodysplastic syndrome (MDS) that includes molecular information?
  0.50 CME

  0.50 ABIM MOC

  0.50 CE

  0.50 CE
• Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Myeloproliferative Neoplasms: Spotlight on New Data From New Orleans 2022
  Medscape Education Oncology, January 2023
  Catch up on the biggest news in AML, MDS, and MPNs from the 2022 Winter Hematology meeting.
  0.50 CME

  0.50 ABIM MOC
• Let’s Talk: Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome
  Medscape Education Oncology, December 2022
  Are you able to risk stratify and personalize treatment for patients with acute myeloid leukemia (AML) and higher-risk myelodysplastic syndrome (HR-MDS)?
  1.50 CME

  1.50 ABIM MOC

  1.50 CE

  1.50 CE
• Elevating Equity in Caring for Patients With Hematologic Malignancies
  Medscape Education Oncology, December 2022
  Experts discuss best practices for advancing health equity through patient and community engagement and empowerment.
  1.00 CME

  1.00 ABIM MOC

  1.00 CE

• Medscape Onsite: Prostate and Bladder Cancer Updates From the Annual American Genitourinary Meeting
  Medscape Education Oncology, March 2023
  Get the latest data on prostate and bladder cancer from the 2023 winter meetings.
  0.50 CME

  0.50 ABIM MOC

• Advanced/Metastatic TNBC in the Clinic: Optimizing Conversations and Shared Decision-Making With the Patient
  Medscape Education Cardiology, August 2023
  Do you know how to have difficult conversations with patients? We can always improve in this area; pick up more tips in this clinical scenario!
  0.25 CME

  0.25 ABIM MOC
• Emerging Therapies for Triple-Negative Breast Cancer: Sharing Expert Perspectives
  Medscape Education Cardiology, September 2022
  Do you know how to optimally sequence treatments for triple-negative breast cancer (TNBC)? And do you feel confident managing their potential side effects?
  0.50 CPD
• Adverse Event Management of TROP2-Targeting Antibody-Drug Conjugates (ADCs)
  Medscape Education Oncology, July 2023
  Do you know what the most common adverse events are with the various TROP2-targeting ADCs?
  0.50 CME

  0.50 ABIM MOC

  0.50 CE

  0.50 CE
• Minimizing Disparities in Breast Cancer to Enhance Equitable Cancer Care
  Medscape Education Oncology, March 2023
  Did you know Black women have the highest breast cancer mortality rate of any racial/ethnic group?
  0.50 CME

  0.50 ABIM MOC

  0.50 CE

  0.50 CE

• Nursing Pearls for Integrating CAR T-Cell Therapies Into Clinical Practice
  Medscape Education Nurses, June 2023
  Dr Acharya summarizes the key clinical data and nursing management approaches for patients receiving chimeric antigen receptor (CAR) T-cell therapy.